“Achiziționarea medicamentelor necesare pentru realizarea Programului Național de Răspuns la Tuberculoză pentru anul 2025”

Enquiry period

with 12.09.2024 09:40
to 23.09.2024 14:00

Bidding period

with 23.09.2024 14:00
to 29.10.2024 13:00

Auction

with 30.10.2024 09:00
to 30.10.2024 14:05

Evaluation

Contract

Status Evaluation

Estimated value without VAT 13 830 473 MDL

Period of clarifications: 12 Sep 2024, 9:40 - 23 Sep 2024, 14:00

Submission of proposals: 23 Sep 2024, 14:00 - 29 Oct 2024, 13:00

Supplier technical support:

(+373) 79999801

Description
Clarifications (0)

“Achiziționarea medicamentelor necesare pentru realizarea Programului Național de Răspuns la Tuberculoză pentru anul 2025”

Documents

Information about customer

Title

CENTRUL PENTRU ACHIZITII PUBLICE CENTRALIZATE IN SANATATE

Fiscal code/IDNO

1016601000212

Address

MD-2005, MOLDOVA, mun.Chişinău, locality, mun. Chișinău MD-2005, bd. Grigore Vieru, 22/2

Web site

---

The contact person

Full name

Macari Doina

Contact phone

+37322222490

E-mail

doina.macari@capcs.md

Purchase data

Date created

12 Sep 2024, 9:29

Date modified

12 Sep 2024, 14:09

Achizitii.md ID

21276871

MTender ID

ocds-b3wdp1-MD-1726122585997

CPV

33600000-6 - Produse farmaceutice

Type of procedure

Open tender

Award criteria

The lowest price

Funding sources

20227942

List of lots

Lot nr. 1 - Bedaquilinum 100 mg

Budget: 5171997.59 MDL

Active

Go to lot

Lot nr. 2 - Clofaziminum 100 mg

Budget: 359546.3 MDL

Active

Go to lot

Lot nr. 3 - Cycloserinum 250 mg

Budget: 813451.22 MDL

Active

Go to lot

Lot nr. 4 - Delamanidum 50 mg

Budget: 208382.22 MDL

Purchase has not taken place

Go to lot

Lot nr. 5 - Ethambutolum (Ethambutoli hydrochloridum) 400 mg

Budget: 450000.0 MDL

Active

Go to lot

Lot nr. 6 - Isoniazidum 100 mg

Budget: 33402.78 MDL

Active

Go to lot

Lot nr. 7 - Isoniazidum 300 mg

Budget: 112270.0 MDL

Active

Go to lot

Lot nr. 8 - Linezolidum 600 mg

Budget: 682705.53 MDL

Active

Go to lot

Lot nr. 9 - Moxifloxacinum 400 mg

Budget: 2287882.94 MDL

Active

Go to lot

Lot nr. 10 - Pretomanidum 200 mg

Budget: 1533157.41 MDL

Active

Go to lot

Lot nr. 11 - Prothionamidum 250 mg

Budget: 23862.89 MDL

Purchase has not taken place

Go to lot

Lot nr. 12 - Pyrazinamidum 400 mg

Budget: 161334.61 MDL

Active

Go to lot

Lot nr. 13 - Pyridoxinum 25 mg

Budget: 77777.78 MDL

Active

Go to lot

Lot nr. 14 - Rifampicinum 300 mg

Budget: 279998.89 MDL

Active

Go to lot

Lot nr. 15 - Rifampicinum + Isoniazidum 150 mg + 75 mg

Budget: 239166.67 MDL

Active

Go to lot

Lot nr. 16 - Rifampicinum + Isoniazidum + Pyrazinamidum + Ethambutolum 150 mg + 75 mg + 400 mg + 275 mg

Budget: 233333.33 MDL

Active

Go to lot

Lot nr. 17 - Rifapentinum 300 mg

Budget: 529451.0 MDL

Active

Go to lot

Lot nr. 18 - Spiritus aethylicus 96% 1000 ml

Budget: 6400.0 MDL

Active

Go to lot

Lot nr. 19 - Tuberculinum PPD 2UT/doza (10 doze)

Budget: 626351.84 MDL

Active

Go to lot

Documents of the procurement procedure

Cerere de participare_Model

Bidding Documents

Cerere de participare_Model

12.09.24 09:40

Documentatia standard T.signed

Bidding Documents

Documentatia standard T.signed

12.09.24 09:40

Anunt de participare T.signed

Bidding Documents

Anunt de participare T.signed

12.09.24 09:40

Propunerea financiară

Technical Specifications

Propunerea financiară

12.09.24 09:40

Scrisoare de garantie bancara_Model

Bidding Documents

Scrisoare de garantie bancara_Model

12.09.24 09:40

Declaratie privind valabilitatea ofertei_Model

Bidding Documents

Declaratie privind valabilitatea ofertei_Model

12.09.24 09:40

Declaratie beneficiari efectivi_Model

Bidding Documents

Declaratie beneficiari efectivi_Model

12.09.24 09:40

contract model

Bidding Documents

contract model

12.09.24 09:40

Propunerea tehnică

Technical Specifications

Propunerea tehnică

12.09.24 09:40

DUAE Model

Bidding Documents

DUAE Model

12.09.24 09:40

Anunt de participare T din 12.09.2024.signed

Bidding Documents

Anunt de participare T din 12.09.2024

12.09.24 14:09

Only authorized platform users may ask questions during the clarification period.